Lupin Australia Pty Ltd

Regulatory activities for this sponsor.

2 result(s) found, displaying 1 to 2

AusPAR: Etanercept

24 February 2021

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Etanercept
Rymti, Etera

9 October 2020

Prescription medicine decision summary

TGA decision: Rymti, Etera (etanercept) is approved to treat rheumatoid arthritis and certain other inflammatory conditions.